Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK ESBJERG ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   3.2% 4.5% 2.3% 2.8% 3.0% 2.1% 18.4% 18.4%   Credit score (0-100)   58 48 64 58 57 67 8 8   Credit rating   BBB BBB BBB BBB BBB A B B   Credit limit (kDKK)   0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,164 5,652 4,985 5,292 4,339 4,509 0.0 0.0   EBITDA   2,620 2,960 2,270 2,319 1,413 1,032 0.0 0.0   EBIT   2,216 2,600 1,910 2,318 1,397 981 0.0 0.0   Pre-tax profit (PTP)   2,214.9 2,597.1 1,894.8 2,304.0 1,700.1 980.2 0.0 0.0   Net earnings   1,750.7 2,025.1 1,469.5 1,793.7 1,325.8 763.6 0.0 0.0   Pre-tax profit without non-rec. items   2,215 2,597 1,895 2,304 1,700 980 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 25.4 223 205 0.0 0.0   Shareholders equity total   300 325 1,795 1,919 474 938 63.1 63.1   Interest-bearing liabilities   400 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,348 1,708 2,708 2,758 1,107 1,618 63.1 63.1   Net Debt   224 -503 -1,062 -312 -522 -765 -63.1 -63.1     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,164 5,652 4,985 5,292 4,339 4,509 0.0 0.0   Gross profit growth   6.3% 9.5% -11.8% 6.2% -18.0% 3.9% -100.0% 0.0%   Employees   6 6 6 6 6 6 0 0   Employee growth %   20.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,348 1,708 2,708 2,758 1,107 1,618 63 63   Balance sheet change%   -39.4% 26.7% 58.5% 1.9% -59.9% 46.2% -96.1% 0.0%   Added value   2,620.1 2,960.2 2,270.3 2,319.3 1,398.1 1,032.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -809 -720 -720 25 182 -69 -205 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   42.9% 46.0% 38.3% 43.8% 32.2% 21.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   124.1% 170.1% 86.5% 84.8% 88.3% 72.3% 0.0% 0.0%   ROI %   171.2% 418.2% 173.9% 124.8% 140.7% 130.8% 0.0% 0.0%   ROE %   189.3% 647.4% 138.6% 96.6% 110.8% 108.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   22.3% 19.0% 66.3% 69.6% 42.9% 58.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   8.6% -17.0% -46.8% -13.5% -36.9% -74.1% 0.0% 0.0%   Gearing %   133.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.4% 1.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.9 2.8 3.1 1.3 2.0 0.0 0.0   Current Ratio   0.6 1.0 2.9 3.1 1.3 2.0 0.0 0.0   Cash and cash equivalent   175.5 502.7 1,062.2 312.0 521.8 765.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -382.1 -65.0 1,691.1 1,788.0 179.5 624.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   437 493 378 387 233 172 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   437 493 378 387 235 172 0 0   EBIT / employee   369 433 318 386 233 164 0 0   Net earnings / employee   292 338 245 299 221 127 0 0